Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000357369 | SCV000394048 | uncertain significance | Hypertyrosinemia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000597442 | SCV000709543 | likely benign | not specified | 2017-06-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000915774 | SCV001060992 | likely benign | Tyrosinemia type I | 2025-01-16 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000915774 | SCV001454941 | uncertain significance | Tyrosinemia type I | 2019-08-06 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003930367 | SCV004742771 | likely benign | FAH-related disorder | 2019-06-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |